tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co (JP:4536)
:4536
Advertisement

Santen Pharmaceutical Co (4536) Revenue

Compare
0 Followers

Santen Pharmaceutical Co Revenue

Santen Pharmaceutical Co had a revenue of 77.23B in the quarter ending Dec 31, 2024, with 1.13%. This bring the company's revenue in the last twelve months to 187.78B, Increased -3.30%. In the fiscal year ending Dec 31, 2024, Santen Pharmaceutical Co had annual revenue of 300.00B with -0.65% growth.
Revenue (ttm)
187.78B
Revenue Growth
-0.06%
P/S Ratio
1.88
Revenue/Employee
¥80,129,274
Employees
3,744
Market Cap
¥563.19B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
300.00B-1.96B-0.65%
Dec 31, 2023
301.96B22.93B+8.22%
Dec 31, 2022
279.04B12.78B+4.80%
Dec 31, 2021
266.26B16.65B+6.67%
Dec 31, 2020
249.60B8.05B+3.33%
Dec 31, 2019
241.56B7.53B+3.22%
Dec 31, 2018
234.03B9.08B+4.04%
Dec 31, 2017
224.94B25.85B+12.98%
Dec 31, 2016
199.10B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis